Cargando…

Risk-group discrimination in node-negative breast cancer using invasion and proliferation markers: 6-year median follow-up

Factors reflecting two major aspects of tumour biology, invasion (urokinase-type plasminogen activator (uPA), plasminogen activator inhibiter (PAI-1), cathepsin D) and proliferation (S-phase fraction (SPF), Ki-67, p53, HER-2/neu), were assessed in 125 node-negative breast cancer patients without adj...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harbeck, N, Dettmar, P, Thomssen, C, Berger, U, Ulm, K, Kates, R, Höfler, H, Jänicke, F, Graeff, H, Schmitt, M
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1999
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362313/ https://www.ncbi.nlm.nih.gov/pubmed/10408848 http://dx.doi.org/10.1038/sj.bjc.6690373

Ejemplares similares

Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc
por: Kuhn, W, et al.
Publicado: (1999)

Prognostic impact of proliferation-associated factors MIB1 (Ki-67) and S-phase in node-negative breast cancer.
por: Dettmar, P., et al.
Publicado: (1997)

Time-varying prognostic impact of tumour biological factors urokinase (uPA), PAI-1 and steroid hormone receptor status in primary breast cancer.
por: Schmitt, M., et al.
Publicado: (1997)

Adjuvant Docetaxel in Node-Negative Breast Cancer Patients: A Randomized Trial of AGO-Breast Study Group, German Breast Group, and EORTC-Pathobiology Group
por: Thomssen, Christoph, et al.
Publicado: (2023)

The effect of median nerve mobilization on two point discrimination
por: Bayram, Gulay Aras, et al.
Publicado: (2022)

Expression of CD3-ζ on T-cells in primary cervical carcinoma and in metastasis-positive and -negative pelvic lymph nodes
por: de Gruijl, T D, et al.
Publicado: (1999)

Chromosomal changes during development and progression of prostate adenocarcinomas
por: Zitzelsberger, H, et al.
Publicado: (2001)

Molecular neural crest cell markers enable discrimination of organophosphates in the murine cardiac embryonic stem cell test
por: Mennen, R.H., et al.
Publicado: (2021)

Analysis of potential markers for detection of submicroscopic lymph node metastases in breast cancer
por: Merrie, A E H, et al.
Publicado: (1999)

Clinicopathologic study associated with long-term survival in Japanese patients with node-negative breast cancer
por: Kato, T, et al.
Publicado: (2000)

Contribution of vascular endothelial growth factor to the Nottingham prognostic index in node-negative breast cancer
por: Coradini, D, et al.
Publicado: (2001)

uPA and PAI-1 as biomarkers in breast cancer: validated for clinical use in level-of-evidence-1 studies
por: Duffy, Michael J, et al.
Publicado: (2014)

Dynamic longitudinal discriminant analysis using multiple longitudinal markers of different types
por: Hughes, David M, et al.
Publicado: (2016)

Prospective evaluation of prognostic factors uPA/PAI-1 in node-negative breast cancer: Phase III NNBC3-Europe trial (AGO, GBG, EORTC-PBG) comparing 6 × FEC versus 3 × FEC/3 × Docetaxel
por: Kantelhardt, Eva J, et al.
Publicado: (2011)

Leucocyte nadir as a marker for chemotherapy efficacy in node-positive breast cancer treated with adjuvant CMF
por: Poikonen, P, et al.
Publicado: (1999)

Trust based attachment
por: Kates-Harbeck, Julian, et al.
Publicado: (2023)

Hevin is down-regulated in many cancers and is a negative regulator of cell growth and proliferation
por: Claeskens, A, et al.
Publicado: (2000)

Long-term quality of life in premenopausal women with node-negative localized breast cancer treated with or without adjuvant chemotherapy
por: Joly, F, et al.
Publicado: (2000)

St. Gallen/Vienna 2021: A Brief Summary of the Consensus Discussion on Customizing Therapies for Women with Early Breast Cancer
por: Thomssen, Christoph, et al.
Publicado: (2021)

Does vascular endothelial growth factor (VEGF) predict local relapse and survival in radiotherapy-treated node-negative breast cancer?
por: Linderholm, B, et al.
Publicado: (1999)

RCAS1 as a tumour progression marker: an independent negative prognostic factor in gallbladder cancer
por: Oshikiri, T, et al.
Publicado: (2001)

Increasing chromosome 1 copy number parallels histological progression in breast carcinogenesis
por: Cummings, M C, et al.
Publicado: (2000)

Primary tumour characteristics and axillary lymph node status in breast cancer
por: Yiangou, C, et al.
Publicado: (1999)

Ejaculation in testicular cancer patients after post-chemotherapy retroperitoneal lymph node dissection
por: Jacobsen, K D, et al.
Publicado: (1999)

Modelling the effects of standard prognostic factors in node-positive breast cancer
por: Sauerbrei, W, et al.
Publicado: (1999)

Neural correlates of abnormal sensory discrimination in laryngeal dystonia
por: Termsarasab, Pichet, et al.
Publicado: (2015)

Sentinel node procedure in Ib cervical cancer: a preliminary series
por: Lantzsch, T, et al.
Publicado: (2001)

Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up.
por: Harbeck, N., et al.
Publicado: (1994)

Medical mistrust, discrimination, and COVID-19 vaccine behaviors among a national sample U.S. adults
por: Allen, Jennifer D., et al.
Publicado: (2022)

What is the Best Latent Structure of Negative Symptoms in Schizophrenia? A Systematic Review
por: Haguiara, Bernardo, et al.
Publicado: (2021)

Nucleus accumbens functional connectivity discriminates medication-overuse headache
por: Torta, D.M., et al.
Publicado: (2016)

Unobserved classes and extra variables in high-dimensional discriminant analysis
por: Fop, Michael, et al.
Publicado: (2022)

Rice BRITTLE CULM 5 (BRITTLE NODE) is Involved in Secondary Cell Wall Formation in the Sclerenchyma Tissue of Nodes
por: Aohara, Tsutomu, et al.
Publicado: (2009)

Strigolactone-Based Node-to-Bud Signaling May Restrain Shoot Branching in Hybrid Aspen
por: Katyayini, Niveditha Umesh, et al.
Publicado: (2019)

Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis
por: Tsurusaki, T, et al.
Publicado: (1999)

Limitations of the nested reverse transcriptase polymerase chain reaction on tyrosinase for the detection of malignant melanoma micrometastases in lymph nodes
por: Calogero, A, et al.
Publicado: (2000)

Gray matter volumes discriminate cognitively impaired and unimpaired people with HIV
por: Schantell, Mikki, et al.
Publicado: (2021)

COVID-19 vaccine hesitancy and racial discrimination among US adults
por: Willis, Don E., et al.
Publicado: (2022)

Discrimination between Gaussian process models: active learning and static constructions
por: Yousefi, Elham, et al.
Publicado: (2023)

LOH at 1p31 (ARHI) and Proliferation in Lymph Node-Negative Breast Cancer
por: Janssen, Emiel A. M., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_21udj1pmoj8lfnap9svlbqp9qs